[HTML][HTML] The emerging role of fatty acid binding protein 7 (FABP7) in cancers

WG Warren, M Osborn, A Yates, SE O'Sullivan - Drug Discovery Today, 2024 - Elsevier
Fatty acid binding protein 7 (FABP7) is an intracellular protein involved in the uptake,
transportation, metabolism, and storage of fatty acids (FAs). FABP7 is upregulated up to 20 …

A novel risk model based on lipid metabolism-associated genes predicts prognosis and indicates immune microenvironment in breast cancer

Z Ye, S Zou, Z Niu, Z Xu, Y Hu - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
Background Breast cancer (BRCA) is the most common tumor in women, and lipid
metabolism involvement has been demonstrated in its tumorigenesis and development …

KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells

B Li, N Ge, Z Pan, C Hou, K Xie, D Wang, J Liu… - BMC Medical …, 2022 - Springer
Background This study attempted to verify the potential of KCNJ14 as a biomarker in
colorectal cancer (CRC). Methods Data on transcriptomics and DNA methylation and the …

Secretome profiling and computational biology of human leiomyoma samples unravel molecular signatures with potential for diagnostic and therapeutic interventions

T Sahar, A Nigam, S Anjum, N Gupta, S Wajid - Reproductive Sciences, 2021 - Springer
In recent years, significant advancements have been made in the way the complex
proteome samples are compared but the ultimate goal of routine biomarker discovery has …

MIB2 promotes the progression of non-small cell lung cancer by regulating cell cycle control pathways

Y Kong, J Li, X Liang, X Zhou - Genes & Genomics, 2023 - Springer
Background Although numerous measures have been used to improve the outcome of lung
cancer patients, lung cancer, as the second most common diagnosed cancer, is still the …

Differential expression of MAP3K7 and TROPONIN C proteins and related perturbations in renal amyloidosis

N Gupta, T Sahar, D Khullar, SK Jain… - Expert Review of …, 2020 - Taylor & Francis
Objectives Renal amyloidosis (RA) is a rare protein misfolding disorder that prompts
progressive renal insufficiency. This study aimed to decipher proteomic changes in human …

The development and clinical applications of proteomics: An Indian perspective

K Taunk, B Kalita, V Kale, V Chanukuppa… - Expert Review of …, 2020 - Taylor & Francis
Introduction Proteomic research has been extensively used to identify potential biomarkers
or targets for various diseases. Advances in mass spectrometry along with data analytics …

[HTML][HTML] Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma

YQ Che, D Wang, P Liu, Y Zhang, Y Luo… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background Diffuse large B-cell lymphoma (DLBCL) is a common subtype of non-Hodgkin's
lymphoma (NHL). We assessed serum biomarkers to identify patients with DLBCL and …

Differential levels of CHMP2B, LLPH, and SLC25A51 proteins in secondary renal amyloidosis

N Gupta, T Sahar, S Khowal, IA Ganaie… - Expert Review of …, 2021 - Taylor & Francis
Objectives Renal amyloidosis (RA) is a rare disease, typically manifested with proteinuria,
nephrotic syndrome, and ultimately leads to renal failure. The present study aims to profile …